Cancer antigen 19-9 (CA 19-9)

Meta Analysis

Matrix: Serum/plasma

Type median CV estimate lower CI limit higher CI limit
Within-subject 22.5 15.8 27.2

References

No meta analysis Reference included in meta calculation Reference not included in meta calculation
Link Estimate of CVi Estimate of CVg Gender State of Well Being Matrix
Vestergaard EM, Hein HO, Meyer H, Grunnet N, Jorgensen J, Wolf H, Orntoft TF, 1999, Clin Chem, 45, 54-61 15.8 102.2 Females Healthy (excl pregnant) Serum
Erden G, Barazi AO, Tezcan G and Yildirimkaya MM, 2008, Scand J Clin Lab Invest, 68, 212-8 27.2 64.24 Mixed Healthy (excl pregnant) Serum
Plebani M, Giacomini A, Beghi L, De Paoli M, Roveroni G, Galleotti F, Corsini A, Fraser CG, 1996, Anticancer Res, 16, 2249-52 15.9 159.0 Mixed Non-healthy (excl pregnant) Serum
Qi Z, Zhang Lin, Chen Y, Ma X et al, 2015, Clin Chim Acta, 450, 233-6 6.76 48.56 Mixed Healthy (excl pregnant) Serum
© 2018 - 2019 This website and its content is copyright of EFLM. All rights reserved. Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following: you may print or download to a local hard disk extracts for your personal and non-commercial use only you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.
European Federation of Clinical Chemistry and Laboratory Medicine
Ms Silvia Cattaneo
Via Carlo Farini 81
20159 Milano - Italy
biologicalvariationdatabase@eflm.eu